Expression of wild-type CFTR suppresses NF-κB-driven inflammatory signalling

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Hunter, Mairi J ^a   Treharne, Kate J ^a   Winter, Alexandra K ^a   Cassidy, Diane M ^a   Land, Stephen ^a   Mehta, Anil ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYAN FLUORESCENT PROTEIN; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DENSITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REPORTER GENE; SIGNAL TRANSDUCTION; STABLE EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; UPREGULATION; WILD TYPE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELA CELLS; HUMANS; IMMUNOBLOTTING; INFLAMMATION; INTERLEUKIN-8; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77955382245     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011598     Document Type: Article

References (51)

1. Welsh MJ, Ramsey BW, Accurso F, Cutting GR (2001) Cystic fibrosis. In: Scriver, et al. (2001) New York: The Metabolic and Molecular Basis of Inherited Disease McGraw-Hill Inc. pp 5121-5188.
2. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, et al. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080.
3. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073.
4. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, et al. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065.
5. Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23: 146-158.
6. Muhlebach MS, Stewart PW, Leigh MW, Noah TL (1999) Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 160: 186-191.
7. Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, et al. (1998) Selective Up-Regulation of Chemokine IL-8 Expression in Cystic Fibrosis Bronchial Gland Cells in Vivo and in Vitro. Am J Pathol 153: 921-930.
8. Verhaeghe C, Remouchamps C, Hennuy B, Vanderplasschen A, Chariot A, et al. (2007) Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem Pharmacol 73: 1982-1994.
9. Verhaeghe C, Delbecque K, de Leval L, Oury C, Bours V (2007) Early inflammation in the airways of a cystic fibrosis foetus. J Cyst Fibros 6: 304-308.
10. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, et al. (2000) Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 23: 121-127.
11. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, et al. (2000) Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 23: 396-403.
12. Muselet-Charlier C, Roque T, Boncoeur E, Chadelat K, Clement A, et al. (2007) Enhanced IL-1beta-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NFkappaB signaling. Biochem Biophys Res Commun 357: 402-407.
13. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15: 194-222.
14. Noah TL, Black HR, Cheng PW, Wood RE, Leigh MW (1997) Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 175: 638-647.
15. Vij N, Mazur S, Zeitlin PL (2009) CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS ONE 4: e4664.
16. Caci E, Caputo A, Hinzpeter A, Arous N, Fanen P, et al. (2008) Evidence for direct CFTR inhibition by CFTRinh-172 based on arginine 347 mutagenesis. Biochem J 413: 135-142
17. Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, et al. (2007) CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung Cell Mol Physiol 292: L383-395.
18. Sheppard DN, Welsh MJ (1999) Structure and function of the CFTR chloride channel. Physiol Rev 79: S23-45.
19. Kongsuphol P, Cassidy D, Hieke B, Treharne KJ, Schreiber R, et al. (2009) Mechanistic insight into control of CFTR by AMPK. J Biol Chem 284: 5645-5653.
20. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, et al. (2002) Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658.
21. Marcorelles P, Montier T, Gillet D, Lagarde N, Ferec C (2007) Evolution of CFTR protein distribution in lung tissue from normal and CF human fetuses. Pediatr Pulmonol 42: 1032-1040.
22. Trezise AE, Chambers JA, Wardle CJ, Gould S, Harris A (1993) Expression of the cystic fibrosis gene in human foetal tissues. Hum Mol Genet 2: 213-218.
23. Rae C, Cherry JI, Land FM, Land SC (2006) Endotoxin-induced nitric oxide production rescues airway growth and maturation in atrophic fetal rat lung explants. Biochem Biophys Res Commun 349: 416-425.
24. Land SC, Darakhshan F (2004) Thymulin evokes IL-6-C/EBPbeta regenerative repair and TNF-alpha silencing during endotoxin exposure in fetal lung explants. Am J Physiol Lung Cell Mol Physiol 286: L473-487.
25. Kramer BW, Kallapur S, Newnham J, Jobe AH (2009) Prenatal inflammation and lung development. Semin Fetal Neonatal Med 14: 2-7.
26. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A (1998) Activation of NFkappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 101: 2598-2605.
27. Carrabino S, Carpani D, Livraghi A, Di Cicco M, Costantini D, et al. (2006) Dysregulated interleukin-8 secretion and NF-kappaB activity in human cystic fibrosis nasal epithelial cells. J Cyst Fibros 5: 113-119.
28. Eidelman O, Srivastava M, Zhang J, Leighton X, Murtie J, et al. (2001) Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway. Mol Med 7: 523-534.
29. Hallows KR, Fitch AC, Richardson CA, Reynolds PR, Clancy JP, et al. (2006) Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation. J Biol Chem 281: 4231-4241.
30. Perez A, Davis PB (2004) Gene profile changes after Pseudomonas aeruginosa exposure in immortalized airway epithelial cells. J Struct Funct Genomics 5: 179-194.
31. Schwiebert LM, Estell K, Propst SM (1999) Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am J Physiol 276: C700-710.
32. Srivastava M, Eidelman O, Pollard HB (1999) Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis. Mol Med 5: 753-767.
33. Weber AJ, Soong G, Bryan R, Saba S, Prince A (2001) Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl2 channel function. Am J Physiol Lung Cell Mol Physiol 281: L71-78.
34. Kerbiriou M, Le Drevo MA, Ferec C, Trouve P (2007) Coupling cystic fibrosis to endoplasmic reticulum stress: Differential role of Grp78 and ATF6. Biochim Biophys Acta 1772: 1236-1249.
35. Kalin N, Claass A, Sommer M, Puchelle E, Tummler B (1999) DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest 103: 1379-1389.
36. Comer DM, Ennis M, McDowell C, Beattie D, Rendall J, et al. (2009) Clinical phenotype of cystic fibrosis patients with the G551D mutation. Quarterly Journal of Medicine 102: 793-798.
37. Dechecchi MC, Nicolis E, Bezzerri V, Vella A, Colombatti M, et al. (2007) MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Am J Respir Cell Mol Biol 36: 615-624.
38. Dechecchi MC, Nicolis E, Norez C, Bezzerri V, Borgatti M, et al. (2008) Antiinflammatory effect of miglustat in bronchial epithelial cells. J Cyst Fibros.
39. Kelly M, Trudel S, Brouillard F, Bouillaud F, Colas J, et al. (2010) Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition. J Pharmacol Exp Ther 333: 60-69.
40. Dudez T, Borot F, Huang S, Kwak BR, Bacchetta M, et al. (2008) CFTR in a lipid raft-TNFR1 complex modulates gap junctional intercellular communication and IL-8 secretion. Biochim Biophys Acta 1783: 779-788.
41. Stanke F, Becker T, Cuppens H, Kumar V, Cassiman JJ, et al. (2006) The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. Hum Genet 119: 331-343.
42. Treharne KJ, Best OG, Mehta A (2009) The phosphorylation status of membrane-bound nucleoside diphosphate kinase in epithelia and the role of AMP. Mol Cell Biochem 329: 107-14.
43. - Channel, but has no Effect on the Cystic Fibrosis Mutant DF508-CFTR. Cellular Physiology and Biochemistry 24: 347-360.
44. Bachhuber T, Almaca J, Aldehni F, Mehta A, Amaral MD, et al. (2008) Regulation of the epithelial Na+ channel by the protein kinase CK2. J Biol Chem 283: 13225-13232.
45. Pagano MA, Arrigoni G, Marin O, Sarno S, Meggio F, et al. (2008) Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis. Biochemistry 47: 7925-7936.
46. Pagano MA, Marin O, Cozza G, Sarno S, Meggio F, et al. (2010) Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2. Biochem J 426: 19-29.
47. Singh NN, Ramji DP (2008) Protein kinase CK2, an important regulator of the inflammatory response? J Mol Med 86: 887-897.
48. Rodriguez MS, Thompson J, Hay RT, Dargemont C (1999) Nuclear Retention of Ikappa Balpha Protects It from Signal-induced Degradation and Inhibits Nuclear Factor kappa B Transcriptional Activation. J Biol Chem 274: 9108-9115.
49. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, et al. (1994) CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10: 38-47.
50. Nagayama S, Kai H, Okiyoneda T, Horikawa S, Miyata T (1999) Characterization of CFTR expression in a human pulmonary mucoepidermoid carcinoma cell line, NCI-H292 cells. FEBS Lett 455: 215-218.
51. Pfaffl MW (2001) A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29: e45.